Vascularity and Survival in Lung Cancer
Author Information
Author(s): LM Chandrachud, N Pendleton, DM Chisholm, MA Horan, AM Schor
Primary Institution: University of Dundee; University of Manchester
Hypothesis
Is vascularity related to age, survival, or other clinical parameters in non-small-cell lung cancer?
Conclusion
Vascularity is not associated with age and has no significant prognostic value in non-small-cell lung cancer.
Supporting Evidence
- Vascularity was not associated with age, sex, tumor type, stage, volume, size, or survival.
- Survival time was generally longer for patients with higher vascularity, but this was not statistically significant.
- Higher tumor volume and stage were associated with lower survival times.
Takeaway
This study looked at whether the blood supply in lung tumors affects how long patients live, and it found that it doesn't really matter.
Methodology
The study analyzed tumor vascularity using three methods in 88 patients with non-small-cell lung cancer who had at least 5 years of follow-up.
Limitations
The study may not account for variations in vascularity among different tumor blocks.
Participant Demographics
67% men, 75% squamous cell carcinoma, age range 37-78 years.
Statistical Information
P-Value
0.06
Confidence Interval
95% CI 52-65%
Statistical Significance
p=0.06
Want to read the original?
Access the complete publication on the publisher's website